GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharmaceutical Co Ltd (XKRX:271980) » Definitions » Other Income (Expense)

Jeil Pharmaceutical Co (XKRX:271980) Other Income (Expense) : ₩-5,425 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Jeil Pharmaceutical Co Other Income (Expense)?

Jeil Pharmaceutical Co's other income expense for the Jeil Pharmaceutical Co's pretax income for the three months ended in Mar. 2025 was ₩-224 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-5,425 Mil.


Jeil Pharmaceutical Co Other Income (Expense) Historical Data

The historical data trend for Jeil Pharmaceutical Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharmaceutical Co Other Income (Expense) Chart

Jeil Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial 643.84 -1,562.98 2,979.20 -1,969.41 -4,535.70

Jeil Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 665.24 -6,935.42 -618.13 2,352.61 -223.86

Jeil Pharmaceutical Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-5,425 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jeil Pharmaceutical Co  (XKRX:271980) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Jeil Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
343, Sapyeong-daero, Seocho-gu, Seoul, KOR, 06543
Jeil Pharmaceutical Co Ltd is engaged in maufacturing and distribution of pharmaceutical products. The company's products include antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, and anticancer drugs.

Jeil Pharmaceutical Co Headlines

No Headlines